CJC (No DAC) + Ipamorelin

CJC (No DAC) + Ipamorelin – Research Use Only (RUO)
Dual Peptide Research Combination
CJC (without DAC) + Ipamorelin is a dual-peptide research combination frequently referenced in laboratory studies involving growth hormone–related signaling pathways, receptor-binding interactions, and endocrine pathway modeling. The non-DAC version of CJC is commonly used in short-duration signaling investigations, while Ipamorelin supports complementary GHRP-related receptor interaction research.
Researchers utilize this combination for its:
Complementary receptor-pathway relevance, useful in dual-signal modeling
Stable peptide profiles, supporting consistent assay performance
Relevance to endocrine and metabolic signaling research
Compatibility with in-vitro and molecular receptor studies
This combination is intended exclusively for laboratory research, assay development, and biochemical pathway investigation.
Research Applications (RUO Only):
Growth hormone signaling pathway modeling
GHRH and GHRP receptor interaction studies
Endocrine regulatory mechanism research
Comparative peptide-interaction investigations
Not for human or veterinary use.